Skip to content
Top Globe News – Lifestyle
Author:
Crystalys Therapeutics / Russo Partners
Crystalys Therapeutics Doses First Patients in New Phase 2 Trial of Dotinurad for Difficult-to-Treat Gout
May 26, 2026